GLP-1 Wars: Obesity Week Highlights, Novo Nordisk vs. Pfizer, and Addiction Breakthroughs episode artwork

EPISODE · Nov 3, 2025 · 1H 22M

GLP-1 Wars: Obesity Week Highlights, Novo Nordisk vs. Pfizer, and Addiction Breakthroughs

from The Plus SideZ: A GLP-1 Guide to Metabolic Health

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Get the latest buzz on GLP-1 therapies and the future of metabolic medicine! This episode provides an in-depth look at what's coming out of Obesity Week in Atlanta, GA, featuring expert insights from Dave Knapp from On the Pen.Key Topics & Breakthroughs:Corporate Battle for Biotech: We break down the surprise counteroffer by Novo Nordisk to acquire Metsera, the obesity biotech company that Pfizer had recently announced it was buying, setting the stage for a major pharmaceutical turf war.Pipeline Watch: Dive into the plethora of new therapies in current clinical trials, including the latest developments from Viking Therapeutics and the push for Oral GLP-1s.GLP-1's New Frontier: Discover the groundbreaking research on GLP-1's potential role in treating alcohol and narcotics addictions. We also discuss Brenipatide and its surprising dual focus on alcohol abuse and asthma.Tune in for a comprehensive review of the medications, mergers, and clinical trials shaping the next generation of weight loss and metabolic treatments.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter,  Producer TikTokInstagram 

Episode metadata supplied by the publisher feed · Published Nov 3, 2025

Embed this episode

Resources for the Community: ___________________________________________________________________ https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55 Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ Get the latest buz...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

GLP-1 Wars: Obesity Week Highlights, Novo Nordisk vs. Pfizer, and Addiction Breakthroughs

0:00 1:22:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Plus SideZ: A GLP-1 Guide to Metabolic Health?

This episode is 1 hour and 22 minutes long.

When was this The Plus SideZ: A GLP-1 Guide to Metabolic Health episode published?

This episode was published on November 3, 2025.

Can I download this The Plus SideZ: A GLP-1 Guide to Metabolic Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!